Acesso livre
Acesso livre

Arquivos do dia: Março 3, 2022

OMS | Pandemia de COVID-19 desencadeou um aumento de 25% na prevalência de ansiedade e depressão ao redor do mundo.

3 Mar, 2022 | 16:55h

Comunicado de imprensa: COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide – World Health Organization

Resumo científico: Mental health and COVID-19: Early evidence of the pandemic’s impact – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

 

Estudo randomizado | Nirsevimabe para prevenção de infecção por vírus respiratório sincicial em neonatos pré-termo e a termo.

3 Mar, 2022 | 16:53h

Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants – New England Journal of Medicine

Comentários:

Nirsevimab Protects Late-Preterm, Term Infants from RSV-Related Lower RTI, Study Finds – AJMC

Nirsevimab Prophylaxis Wards Off RSV Infections in Healthy Infants— Monoclonal antibody showed 74.5% efficacy against RSV infections requiring medical care – MedPage Today (necessário cadastro gratuito)

Conteúdo relacionado: Randomized trial: Single-dose nirsevimab for prevention of RSV in preterm infants

Estudo de coorte | Troponina I de alta sensibilidade após cirurgia cardíaca e mortalidade em 30 dias.

3 Mar, 2022 | 16:51h

High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentários:

Better assessment of risk from heart surgery results in better patient outcomes – McMaster University

NEJM study evaluates levels of HS Troponin after cardiac surgery and risk of death – MedicalResearch

Conteúdo relacionado: Retrospective cohort: Serial high-sensitivity cardiac troponin I after coronary artery bypass grafting may add prognostic information for post-operative decision-making.

 

Comentário no Twitter

 

Estudo randomizado | Aspirina e heparina não fracionada aumentam o risco de hemorragia intracraniana sintomática em pacientes submetidos a tratamento endovascular de AVC isquêmico.

3 Mar, 2022 | 16:50h

Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial – The Lancet (link para o resumo – $ para o texto completo)

Análise sistemática | Causas nacionais, regionais e globais de mortalidade em pacientes de 5 a 19 anos de idade de 2000 a 2019.

3 Mar, 2022 | 16:48h

National, regional, and global causes of mortality in 5–19-year-olds from 2000 to 2019: a systematic analysis – The Lancet Global Health

Comentário convidado: Child and adolescent deaths: a call for strengthening mortality surveillance systems – The Lancet Global Health

M-A | Uso de tocilizumabe e sarilumabe isoladamente ou em combinação com corticosteroides para Covid-19.

3 Mar, 2022 | 16:44h

Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis – BMJ Medicine

Editorial: Treatment of severe covid-19 with interleukin 6 receptor inhibition – BMJ Medicine

Estudo relacionado (publicado recentemente): Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids: A Bayesian Reanalysis of a Previous Meta-analysis – JAMA Network Open

[Comunicado de imprensa – ainda não publicado] Estudo mostra que o tamanho do manguito para aferição da pressão arterial é importante, pois afeta as leituras da medição obtida.

3 Mar, 2022 | 16:42h

Study finds blood pressure cuff size matters, affects blood pressure readings – AHA Newsroom

COVID-19 em pessoas com doenças reumáticas: riscos, desfechos e considerações de tratamento.

3 Mar, 2022 | 16:41h

COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations – Nature Reviews Rheumatology

 

Comentário no Twitter

 

Miocardite após vacinação com BNT162b2 contra COVID-19 entre adolescentes em Hong Kong.

3 Mar, 2022 | 16:38h

Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong – JAMA Pediatrics

Comentário: Study: Dosing change could reduce COVID-19 vaccine heart side effect in teens – UPI

Conteúdos relacionados:

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

Estudo randomizado | Em pacientes com câncer de pulmão em estágio inicial, lobectomia toracoscópica vídeo-assistida está associada com melhor recuperação da função física em 5 semanas em comparação com cirurgia aberta.

3 Mar, 2022 | 16:36h

Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer – NEJM Evidence

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.